Phase II trial of 5-fluorouracil and recombinant interferon alfa-2B in metastatic colorectal carcinoma
- 31 December 1992
- journal article
- clinical trial
- Published by Elsevier in European Journal Of Cancer
- Vol. 28 (11) , 1820-1823
- https://doi.org/10.1016/0959-8049(92)90012-q
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Interferon alpha-2a and 5-fluorouracil for advanced colorectal carcinoma assessment of activity and toxicityCancer, 1990
- Phase II study of fluorouracil and recombinant interferon alfa-2a in previously untreated advanced colorectal carcinoma.Journal of Clinical Oncology, 1990
- Biochemical modulation of fluorouracil: evidence of significant improvement of survival and quality of life in patients with advanced colorectal carcinoma.Journal of Clinical Oncology, 1989
- Prognostic variables in patients with hepatic metastases from colorectal cancer. Importance of medical assessment of liver involvementCancer, 1989
- Reporting results of cancer treatmentCancer, 1981